ClinicalTrials.Veeva

Menu
North America Research Institute | NARI Riverside, CA logo

North America Research Institute | NARI Riverside, CA

Research site

Site insights

Top conditions

Top treatments

MK-2060

Parent organization

This site is a part of North America Research Institute

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Contact this site

Molly Way

Verified by this site

Active trials

1 of 2 total trials

Global Study of MK-2060 (Anti-Factor XI Monoclonal Antibody) in Participants With End Stage Renal Disease Receiving Hemodialysis (FXI Hemodialysis Study) (MK-2060-007)

The purpose of this study is to evaluate the efficacy and safety of two different doses of MK-2060 (a monoclonal antibody against Factor XI) in end s...

Active, not recruiting
End-Stage Renal Disease
End-Stage Kidney Disease
Drug: MK-2060
Drug: Placebo

Trial sponsors

K
Merck Sharp & Dohme (MSD) logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems